Sign in

CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
operating
EIN
112622630
Phone
408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
Open-market buys, last 90 days
$291,587
in 10 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-07-15 HERMS HENRY P VP Finance and CFO Option exercise +280,000 $0.16 $45K 570,575
2013-07-15 HERMS HENRY P VP Finance and CFO Option exercise · Common Stock Purchase Warrants (Right to Buy) −280,000 $0.18 $50K 0
2013-07-15 JOHNSON BRUCE F Director Option exercise +700,000 $0.16 $112K 6,496,196
2013-07-15 JOHNSON BRUCE F Director Option exercise · Common Stock Purchase Warrants (Right to Buy) −700,000 $0.18 $125K 0
2013-07-01 BERMAN ROBERT ANDREW President and CEO Other acquisition +3,447 $0.29 $1,000 6,786
2013-07-01 KUMAR AMIT Director Other acquisition +6,894 $0.29 $2K 72,772
2013-07-01 JOHNSON BRUCE F Director Other acquisition +6,894 $0.29 $2K 5,796,196
2013-05-21 JOHNSON BRUCE F Director Purchase +24,973 $0.30 $7K 5,789,302
2013-05-16 JOHNSON BRUCE F Director Purchase +25,000 $0.31 $8K 5,764,329

Page 34 of 34 · 669 trades